The loss of DAT activity in the basal ganglia, as measured by single-photon emission tomography of DAT, may be a useful diagnostic marker in patients with DYT/PARK-SLC6A3 [3]. The gene discussed is SLC6A3; the disease is late-onset Parkinson disease.